Claudius Llc - Net Worth and Insider Trading
Claudius Llc Net Worth
The estimated net worth of Claudius Llc is at least $178 Million dollars as of 2024-04-26. Claudius Llc is the 10% Owner of MedAssets Inc and owns about 5,674,635 shares of MedAssets Inc (MDAS) stock worth over $178 Million. Claudius Llc is also the of Acura Pharmaceuticals Inc and owns about 0 shares of Acura Pharmaceuticals Inc (ACUR) stock worth over $0. Details can be seen in Claudius Llc's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Claudius Llc has not made any transactions after 2017-12-14 and currently still holds the listed stock(s).
Transaction Summary of Claudius Llc
Claudius Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Claudius Llc owns 2 companies in total, including Acura Pharmaceuticals Inc (ACUR) , and MedAssets Inc (MDAS) .
Click here to see the complete history of Claudius Llc’s form 4 insider trades.
Insider Ownership Summary of Claudius Llc
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ACUR | Acura Pharmaceuticals Inc | 2017-12-14 | 10 percent owner |
MDAS | MedAssets Inc | 2010-05-18 | 10 percent owner |
Claudius Llc Latest Holdings Summary
Claudius Llc currently owns a total of 2 stocks. Among these stocks, Claudius Llc owns 5,674,635 shares of MedAssets Inc (MDAS) as of May 18, 2010, with a value of $178 Million and a weighting of 100%. Claudius Llc also owns 0 shares of Acura Pharmaceuticals Inc (ACUR) as of December 14, 2017, with a value of $0 and a weighting of 0%.
Latest Holdings of Claudius Llc
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
MDAS | MedAssets Inc | 2010-05-18 | 5,674,635 | 31.35 | 177,899,807 |
ACUR | Acura Pharmaceuticals Inc | 2017-12-14 | 0 | 0.01 | 0 |
Holding Weightings of Claudius Llc
Claudius Llc Form 4 Trading Tracker
According to the SEC Form 4 filings, Claudius Llc has made a total of 0 transactions in MedAssets Inc (MDAS) over the past 5 years. The most-recent trade in MedAssets Inc is the sale of 30,856 shares on May 18, 2010, which brought Claudius Llc around $743,938.
According to the SEC Form 4 filings, Claudius Llc has made a total of 0 transactions in Acura Pharmaceuticals Inc (ACUR) over the past 5 years. The most-recent trade in Acura Pharmaceuticals Inc is the sale of 2,195,734 shares on December 14, 2017, which brought Claudius Llc around $219,573.
Insider Trading History of Claudius Llc
- 1
Claudius Llc Trading Performance
Claudius Llc Ownership Network
Ownership Network List of Claudius Llc
Ownership Network Relation of Claudius Llc
Claudius Llc Owned Company Details
What does Acura Pharmaceuticals Inc do?
Who are the key executives at Acura Pharmaceuticals Inc?
Claudius Llc is the 10 percent owner of Acura Pharmaceuticals Inc. Other key executives at Acura Pharmaceuticals Inc include VP & Corporate Development James F Emigh , VP & Treasurer & Controller Robert A Seiser , and President & CEO Robert B Jones .
Acura Pharmaceuticals Inc (ACUR) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Acura Pharmaceuticals Inc (ACUR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Acura Pharmaceuticals Inc (ACUR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Acura Pharmaceuticals Inc (ACUR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Acura Pharmaceuticals Inc Insider Transactions
Claudius Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Claudius Llc. You might contact Claudius Llc via mailing address: C/o Galen Associates 610 Fifth Avenue 5th Floor New York Ny 10020.